Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
22.40
+2.00 (9.80%)
At close: Jan 22, 2026, 4:00 PM EST
22.84
+0.44 (1.96%)
After-hours: Jan 22, 2026, 6:13 PM EST
Aktis Oncology Revenue
Aktis Oncology had revenue of $933.00K in the quarter ending December 31, 2024. This brings the company's revenue in the last twelve months to $5.56M. In the year 2024, Aktis Oncology had annual revenue of $1.49M.
Revenue (ttm)
$5.56M
Revenue Growth
n/a
P/S Ratio
3.20
Revenue / Employee
$73,158
Employees
76
Market Cap
1.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.49M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAKTS News
- 9 days ago - Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 13 days ago - U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO - Seeking Alpha
- 13 days ago - Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets - Business Wire
- 14 days ago - Aktis Oncology prices upsized US IPO at $18 per share - Reuters
- 14 days ago - Aktis Oncology Announces Pricing of its Upsized Initial Public Offering - GlobeNewsWire
- 16 days ago - Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies - Seeking Alpha
- 19 days ago - U.S. IPO Weekly Recap: Small Issuers And SPACs Join The Pipeline In Short Holiday Week - Seeking Alpha
- 4 weeks ago - Aktis Oncology files for US IPO as biotech listings rebound - Reuters